NasdaqGS:CARLMedical Equipment
Carlsmed (CARL) Stock Revenue Surge Meets A Wider Loss Per Share
Carlsmed stock barely flinched after earnings, closing up just 1% to US$13.70. That muted move sits against a report that put one issue front and center for investors. Revenue reached US$18.94m in Q2 while the company still reported a net loss of US$10.51m. The real story is the widening loss per share. Basic earnings per share declined to US$0.39 in Q2 from US$0.32 in Q1.
Is Carlsmed’s 5.9x P/S multiple a genuine discount to high growth peers, or a warning sign given ongoing losses? Compare...